43
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

, , , , &
Pages 3853-3860 | Published online: 01 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rong Zhao, Zhongguo Liang, Kaihua Chen & Xiaodong Zhu. (2023) Nomogram Based on Hemoglobin, Albumin, Lymphocyte and Platelet Score to Predict Overall Survival in Patients with T3-4N0-1 Nasopharyngeal Carcinoma. Journal of Inflammation Research 16, pages 1995-2006.
Read now
Qiulu Zhong, Danjing Luo, Xiangde Li, Qinghua Du, Qianfu Liang, Wenqi Liu, Jian Li & Xiaodong Zhu. (2023) The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis. Cancer Biology & Therapy 24:1.
Read now
Rong Zhao, Zhongguo Liang, Kaihua Chen & Xiaodong Zhu. (2022) Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma. Journal of Inflammation Research 15, pages 2971-2981.
Read now
Yu-Ting Jiang, Kai-Hua Chen, Zhong-Guo Liang, Jie Yang, Song Qu, Ling Li & Xiao-Dong Zhu. (2022) A Nomogram to Identify the Optimal Candidates for Induction Chemotherapy in Advanced N-Stage Nasopharyngeal Carcinoma. Cancer Management and Research 14, pages 2583-2596.
Read now

Articles from other publishers (19)

An-An Xu, Jing-Jing Miao, Lin Wang, An-Chuan Li, Fei Han, Xun-Fan Shao, Zhi-Wen Mo, Shao-Min Huang, Ya-Wei Yuan, Xiao-Wu Deng & Chong Zhao. (2023) Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis. Radiation Oncology 18:1.
Crossref
Ying Li, Jianping Bi, Guoliang Pi, Hanping He, Yanping Li, Dandan Zheng, Zecheng Wei & Guang Han. (2023) Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer Medicine 12:8, pages 9449-9457.
Crossref
Tingting Quan, Wenlong Guan, Wenjie Huang, Chunyan Cui, Haojiang Li, Guangying Ruan, Lizhi Liu, Qin Zhao & Huali Ma. (2022) Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma. Oral Oncology 135, pages 106230.
Crossref
Jingfeng Zong, Pengjie Ji, Cheng Lin, Ruiting Zhang, Yuebing Chen, Qiongjiao Lu, Xiane Peng, Jianji Pan & Shaojun Lin. (2022) Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma. Oral Oncology 131, pages 105972.
Crossref
Shan-Shan Yang, Yi-Shan Wu, Ya-Jun Pang, Su-Ming Xiao, Bao-Yu Zhang, Zhi-Qiao Liu, En-Ni Chen, Xu Zhang, Pu-Yun OuYang & Fang-Yun Xie. (2022) Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma. European Radiology 32:6, pages 3649-3660.
Crossref
Chao Yang, Zekun Jiang, Tingting Cheng, Rongrong Zhou, Guangcan Wang, Di Jing, Linlin Bo, Pu Huang, Jianbo Wang, Daizhou Zhang, Jianwei Jiang, Xing Wang, Hua Lu, Zijian Zhang & Dengwang Li. (2022) Radiomics for Predicting Response of Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology 12.
Crossref
Si-Qi Tang, Lei Chen, Wen-Fei Li, Anthony T.C. Chan, Shao Hui Huang, Melvin L.K. Chua, Brian O'Sullivan, Anne W.M. Lee, Nancy Y. Lee, Yuan Zhang, Yu-Pei Chen, Cheng Xu, Ying Sun, Ling-Long Tang & Jun Ma. (2022) Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial. Radiotherapy and Oncology 167, pages 179-186.
Crossref
Shan-Shan Yang, Yi-Shan Wu, Wei-Chao Chen, Jun Zhang, Su-Ming Xiao, Bao-Yu Zhang, Zhi-Qiao Liu, En-Ni Chen, Xu Zhang, Pu-Yun OuYang & Fang-Yun Xie. (2021) Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 49:3, pages 980-991.
Crossref
Xi Chen, Yingxue Li, Xiang Li, Xun Cao, Yanqun Xiang, Weixiong Xia, Jianpeng Li, Mingyong Gao, Yuyao Sun, Kuiyuan Liu, Mengyun Qiang, Chixiong Liang, Jingjing Miao, Zhuochen Cai, Xiang Guo, Chaofeng Li, Guotong Xie & Xing Lv. (2021) An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features. Oral Oncology 118, pages 105335.
Crossref
Minmin Li, Bin Zhang, Qiuying Chen, Lu Zhang, Xiaokai Mo, Zhuozhi Chen, Zhe Jin, Luyan Chen, Jingjing You & Shuixing Zhang. (2021) Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score‐matching studies. Head & Neck 43:6, pages 1912-1927.
Crossref
Mengyun Qiang, Chaofeng Li, Yuyao Sun, Ying Sun, Liangru Ke, Chuanmiao Xie, Tao Zhang, Yujian Zou, Wenze Qiu, Mingyong Gao, Yingxue Li, Xiang Li, Zejiang Zhan, Kuiyuan Liu, Xi Chen, Chixiong Liang, Qiuyan Chen, Haiqiang Mai, Guotong Xie, Xiang Guo & Xing Lv. (2021) A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma. JNCI: Journal of the National Cancer Institute 113:5, pages 606-615.
Crossref
Lin Lai, Xinyu Chen, Chuxiao Zhang, Xishan Chen, Li Chen, Ge Tian & Xiaodong Zhu. (2021) Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Omer Aftab, Shufang Liao, Rongjun Zhang, Nan Tang, Meiqing Luo, Bin Zhang, Sanjeev Shahi, Raju Rai, Jazib Ali & Wei Jiang. (2020) Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma. Radiation Oncology 15:1.
Crossref
Xi Chen, Xun Cao, Bingzhong Jing, Weixiong Xia, Liangru Ke, Yanqun Xiang, Kuiyuan Liu, Mengyun Qiang, Chixiong Liang, Jianpeng Li, Mingyong Gao, Wangzhong Li, Jingjing Miao, Guoying Liu, Zhuochen Cai, Shuhui Lv, Xiang Guo, Chaofeng Li & Xing Lv. (2020) Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma. Frontiers in Oncology 10.
Crossref
Xue-Song Sun, Bei-Bei Xiao, Zi-Jian Lu, Sai-Lan Liu, Qiu-Yan Chen, Li Yuan, Lin-Quan Tang & Hai-Qiang Mai. (2020) Stratification of Candidates for Induction Chemotherapy in Stage III-IV Nasopharyngeal Carcinoma: A Large Cohort Study Based on a Comprehensive Prognostic Model. Frontiers in Oncology 10.
Crossref
Hao Peng, Di Dong, Meng-Jie Fang, Lu Li, Ling-Long Tang, Lei Chen, Wen-Fei Li, Yan-Ping Mao, Wei Fan, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Ying Sun, Jie Tian & Jun Ma. (2019) Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma. Clinical Cancer Research 25:14, pages 4271-4279.
Crossref
Qiaojuan Guo, Tianzhu Lu, Shao Hui Huang, Brian O'Sullivan, Jingfeng Zong, Youping Xiao, Wei Xu, Chuanben Chen, Sufang Qiu, Luying Xu, Wei Zheng, Yunbin Chen, Shaojun Lin & Jianji Pan. (2019) Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM. Oral Oncology 91, pages 113-120.
Crossref
Mei Liu, Wei You, Yi-Bing Song, Ji-Dong Miao, Xiu-Bo Zhong, Dian-Kun Cai, Lun Xu, Lu-Feng Xie & Yang Gao. (2018) The Changing Role of Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Updated Systemic Review and Network Meta-Analysis. Frontiers in Oncology 8.
Crossref
Jian Zhang, Hao Peng, Wen-Fei Li, Yuan Zhang, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Ying Sun & Jun Ma. (2018) Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma. BMC Cancer 18:1.
Crossref